[Experimental study on xiaoliu decoction in treating tumor and modulating immune function].

Area of Science:

• Traditional Chinese Medicine
• Immunology
• Oncology

Context:

• The study investigates the therapeutic potential of Xiaoliu decoction (XLD), a traditional Chinese medicine formulation.
• Cancer treatment often involves chemotherapy, which can lead to immunosuppression.
• Understanding novel therapeutic agents that can enhance anti-tumor immunity is crucial.

Purpose:

• To evaluate the anti-tumor efficacy of XLD.
• To assess XLD's ability to modulate immune function in a tumor-bearing model.
• To explore the underlying mechanisms of XLD's action, including its effect on tumor cell apoptosis.

Summary:

• Xiaoliu decoction (XLD) exhibited a tumor suppressive rate exceeding 30% in S180 tumor-bearing mice.
• XLD treatment increased lymphocyte transformation rates, natural killer (NK) cell activity, and tumor necrosis factor alpha (TNFα) levels.
• In vitro studies showed that XLD accelerates tumor cell apoptosis and demonstrated a trend towards enhancing chemotherapy's tumor-suppressing effects.

Impact:

• XLD possesses significant anti-tumor properties.
• The findings suggest XLD can elevate host immune function.
• XLD may serve as a complementary therapy to alleviate chemotherapy-induced immunosuppression.